K210627 is an FDA 510(k) clearance for the Breezeway II. Classified as Introducer, Catheter (product code DYB), Class II - Special Controls.
Submitted by Oscor, Inc. (Palm Harbor, US). The FDA issued a Cleared decision on June 3, 2021 after a review of 93 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1340 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Oscor, Inc. devices